T Cells: Warriors of SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T Cells: Warriors of SARS-CoV-2 Infection

Published:2021-01 Issue:1 Volume:42 Page:18-30
ISSN:1471-4906
Container-title:Trends in Immunology
language:en
Short-container-title:Trends in Immunology

Author:

de Candia Paola,Prattichizzo Francesco,Garavelli Silvia,Matarese Giuseppe^ORCID

Funder

Italian Ministry of Health Ricerca Corrente - IRCCS MultiMedica

Fondazione Italiana Sclerosi Multipla

FISM

Progetti di Rilevante Interesse Nazionale

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference128 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

2. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

4. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction;Mahase;BMJ,2020

5. Clinical characteristics of coronavirus disease 2019 in China;Guan;N. Engl. J. Med.,2020

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors;2024-07-23

2. The Role of Cytokines and T Cells as Mediators of Inflammatory Pathology in Type 1 Diabetes and COVID-19;Pediatric Annals;2024-07

3. SARS-CoV-2 ORF8 modulates lung inflammation and clinical disease progression;PLOS Pathogens;2024-05-23

4. Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate;Advanced Healthcare Materials;2024-05-17

5. Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024;MMWR. Morbidity and Mortality Weekly Report;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3